封面
市场调查报告书
商品编码
1098620

布氏桿菌症疫苗的市场规模、占有率、展望、机会 (2022年~2030年):各类型 (RB51疫苗、S19疫苗、B19疫苗、其他)、用途 (牛、羊、山羊、其他)、地区

Brucellosis Vaccines Market, by Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others ), by Application (Cattle, Sheep, Goat and Others ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 149 Pages | 商品交期: 2-3个工作天内

价格
简介目录

布氏桿菌症的盛行率增加促进在预测期间内的全球布氏桿菌症疫苗市场成长。

本报告提供全球布氏桿菌症疫苗的市场调查,市场定义和概要,市场成长的各种影响因素分析,法律制度,市场规模的变化、预测,各种区分、各地区/主要国家的明细,竞争环境,主要企业简介等彙整资讯。

目录

第1章 调查目的、前提条件

第2章 市场概要

第3章 市场动态、法规、趋势分析

  • 促进因素
  • 阻碍因素
  • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的展开
  • 产品销售
  • 法规指南
  • 收购、联盟、合作
  • 流行病学
  • PEST分析

第4章 全球布氏桿菌症疫苗市场:COVID-19影响

  • 经济影响
  • 需求与供给的分析

第5章 全球布氏桿菌症疫苗市场:各类型

  • RB51疫苗
  • S19疫苗
  • B19疫苗
  • 其他(45/20疫苗,SR82疫苗等)

第6章 全球布氏桿菌症疫苗市场:各用途

  • 绵羊
  • 山羊
  • 其他(猪,马等)

第7章 全球布氏桿菌症疫苗市场:各地区

  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争情形

  • 竞争概述
    • Merck &Co., Inc.
    • CZ Vaccines
    • Colorado Serum Company
    • Indian Immunologicals Ltd.
    • Hester Biosciences Limited
    • Veterinary Technologies Corporation
    • Jordan Bio-industries Center
    • Laboratorios Tornel
    • Fivet Animal Health
    • VETAL Animal Health Products Inc.

第9章 Section

简介目录
Product Code: CMI5038

Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.

Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.

Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.

In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.

Market Dynamics

Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.

According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.

Key features of the study:

  • This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market

Detailed Segmentation:

  • Global Brucellosis Vaccines Market, By Type:
    • RB51 Vaccine
    • S19 Vaccine
    • B19 Vaccine
    • Others (45/20 vaccine, SR82 vaccine, etc.)
  • Global Brucellosis Vaccines Market, By Application:
    • Cattle
    • Sheep
    • Goat
    • Others (swine, horses, etc.)
  • Global Brucellosis Vaccines Market, By Region:
    • North America
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Competitive Snapshot
      • Merck & Co., Inc.*
      • Company Overview
      • Application Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • CZ Vaccines
      • Colorado Serum Company
      • Indian Immunologicals Ltd.
      • Hester Biosciences Limited
      • Veterinary Technologies Corporation
      • Jordan Bio-industries Center
      • Laboratorios Tornel
      • Fivet Animal Health
      • VETAL Animal Health Products Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Launch
  • Regulatory Guidelines
  • Acquisitions, Collaborations, & Partnerships
  • Epidemiology
  • PEST Analysis

4. Global Brucellosis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Supply and Demand Analysis

5. Global Brucellosis Vaccines Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • RB51 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • S19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • B19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (45/20 vaccine, SR82 vaccine, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Brucellosis Vaccines Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cattle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Sheep
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Goat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (swine, horses, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Brucellosis Vaccines Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • North America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Competitive Snapshot
    • Merck & Co., Inc.*
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CZ Vaccines
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Colorado Serum Company
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Indian Immunologicals Ltd.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hester Biosciences Limited
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Veterinary Technologies Corporation
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Jordan Bio-industries Center
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Laboratorios Tornel
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fivet Animal Health
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • VETAL Animal Health Products Inc.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact